ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,821Medicare Part D Prescriptions Filled, Including Refills

Rank: 435 out of 5176

$855K Total Retail Price of All Prescriptions

Rank: 388 out of 5176

563 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 9,764 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 508 413 1 4
OMEPRAZOLE 378 319 2 3
AMLODIPINE BESYLATE 336 293 3 2
SIMVASTATIN 332 267 4 1
LOSARTAN POTASSIUM 239 234 5 14
METOPROLOL SUCCINATE 187 149 6 11
FUROSEMIDE 181 155 7 8
ATENOLOL 156 137 8 12
CITALOPRAM HBR 155 120 9 31
LISINOPRIL 154 119 10 5
GABAPENTIN 142 123 11 21
PRAVASTATIN SODIUM 142 109 11 23
HYDROCHLOROTHIAZIDE 141 120 13 10
METFORMIN HCL ER 135 99 14 57
HYDROCODONE-ACETAMINOPHEN 132 94 S3 15 27
ALENDRONATE SODIUM 126 107 16 18
ZOLPIDEM TARTRATE 122 78 17 17
METOPROLOL TARTRATE 118 91 18 6
PAROXETINE HCL 118 89 18 93
RAMIPRIL 116 110 20 50
PANTOPRAZOLE SODIUM 111 87 21 61
TAMSULOSIN HCL 108 97 22 20
GLIMEPIRIDE 105 99 23 37
TRAMADOL HCL 104 97 24 40
ATORVASTATIN CALCIUM 102 87 25 9
SERTRALINE HCL 100 70 26 30
NEXIUM 98 78 27 16
FLUTICASONE PROPIONATE 97 83 28 38
BENAZEPRIL HCL 95 76 29 131
CARVEDILOL 93 92 30 24
ALLOPURINOL 92 92 31 41
JANUVIA 91 82 32 25
DIGOXIN 89 89 33 56
SINGULAIR 88 69 34 62
AZITHROMYCIN 87 72 35 42
METFORMIN HCL 85 69 36 7
POTASSIUM CHLORIDE 84 77 37 34
PREDNISONE 83 70 38 52
ENALAPRIL MALEATE 83 82 38 22
CYMBALTA 82 68 40 90
CIPROFLOXACIN HCL 82 72 40 84
QUINAPRIL HCL 75 59 42 82
FAMOTIDINE 75 54 42 58
EXELON 73 72 44 162
LABETALOL HCL 73 63 44 114
NAMENDA 73 61 44 47
DIOVAN 72 62 47 19
SPIRIVA 70 59 48 54
CLONIDINE HCL 70 58 48 79
ESCITALOPRAM OXALATE 66 63 50 89
TRICOR 66 36 50 148
FENOFIBRATE 66 45 50 102
SPIRONOLACTONE 64 55 53 88
FLUOXETINE HCL 63 17 54 132
DONEPEZIL HCL 62 58 55 28
WARFARIN SODIUM 61 61 56 13
BENICAR 61 42 56 100
OXYBUTYNIN CHLORIDE 57 46 58 227
TRAMADOL HCL-ACETAMINOPHEN 56 54 59 116
RANITIDINE HCL 56 49 59 36
EVISTA 53 53 61 65
BUSPIRONE HCL 52 26 62 183
KLOR-CON M10 52 52 62 248
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.